{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:55:39Z","timestamp":1791478539908,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:00:00Z","timestamp":1534809600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"BioStruct-X","award":["grant agreement No. 283570"],"award-info":[{"award-number":["grant agreement No. 283570"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Inorg Chem"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00775-018-1605-1","type":"journal-article","created":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T13:34:36Z","timestamp":1534858476000},"page":"1219-1226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The structure of the human glutaminyl cyclase\u2013SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2574-3911","authenticated-orcid":false,"given":"Cecilia","family":"Pozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2302-1464","authenticated-orcid":false,"given":"Flavio","family":"Di Pisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0709-2537","authenticated-orcid":false,"given":"Manuela","family":"Benvenuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4824-7478","authenticated-orcid":false,"given":"Stefano","family":"Mangani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,21]]},"reference":[{"key":"1605_CR1","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1073\/pnas.84.11.3628","volume":"84","author":"WH Fischer","year":"1987","unstructured":"Fischer WH, Spiess J (1987) Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides. PNAS 84:3628\u20133632. https:\/\/doi.org\/10.1073\/pnas.84.11.3628","journal-title":"PNAS"},{"key":"1605_CR2","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1016\/S0021-9258(18)47446-7","volume":"262","author":"WH Busby","year":"1987","unstructured":"Busby WH, Quackenbush GE, Humm J et al (1987) An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla, and lymphocytes. J Biol Chem 262:8532\u20138536","journal-title":"J Biol Chem"},{"key":"1605_CR3","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.biocel.2010.08.015","volume":"42","author":"AP Gunn","year":"2010","unstructured":"Gunn AP, Masters CL, Cherny RA (2010) Pyroglutamate-A\u03b2: role in the natural history of Alzheimer\u2019s disease. Int J Biochem Cell Biol 42:1915\u20131918. https:\/\/doi.org\/10.1016\/j.biocel.2010.08.015","journal-title":"Int J Biochem Cell Biol"},{"key":"1605_CR4","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3233\/JAD-121945","volume":"35","author":"O Wirths","year":"2013","unstructured":"Wirths O, Hillmann A, Pradier L et al (2013) Oligomeric pyroglutamate amyloid-\u03b2 is present in microglia and a subfraction of vessels in patients with Alzheimer\u2019s disease: implications for Immunotherapy. J Alzheimers Dis 35:741\u2013749. https:\/\/doi.org\/10.3233\/JAD-121945","journal-title":"J Alzheimers Dis"},{"key":"1605_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000353634","volume":"14","author":"G Wu","year":"2014","unstructured":"Wu G, Miller RA, Connolly B et al (2014) Pyroglutamate-modified amyloid-\u03b2 protein demonstrates similar properties in an Alzheimer\u2019s disease familial mutant knock-in mouse and Alzheimer\u2019s disease brain. Neurodegener Dis 14:53\u201366. https:\/\/doi.org\/10.1159\/000353634","journal-title":"Neurodegener Dis"},{"key":"1605_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-014-1375-y","volume":"129","author":"DR Thal","year":"2015","unstructured":"Thal DR, Walter J, Saido TC, F\u00e4ndrich M (2015) Neuropathology and biochemistry of A\u03b2 and its aggregates in Alzheimer\u2019s disease. Acta Neuropathol 129:167\u2013182. https:\/\/doi.org\/10.1007\/s00401-014-1375-y","journal-title":"Acta Neuropathol"},{"key":"1605_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1006\/bbrc.2000.3490","volume":"276","author":"Y Harigaya","year":"2000","unstructured":"Harigaya Y, Saido TC, Eckman CB et al (2000) Amyloid \u03b2 protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer\u2019s disease brain. Biochem Biophys Res Commun 276:422\u2013427. https:\/\/doi.org\/10.1006\/bbrc.2000.3490","journal-title":"Biochem Biophys Res Commun"},{"key":"1605_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0304-3940(96)12970-0","volume":"215","author":"TC Saido","year":"1996","unstructured":"Saido TC, Yamao-Harigaya W, Iwatsubo T, Kawashima S (1996) Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain. Neurosci Lett 215:173\u2013176","journal-title":"Neurosci Lett"},{"key":"1605_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1001\/archneurol.2007.56","volume":"65","author":"C Soto","year":"2008","unstructured":"Soto C, Estrada LD (2008) Protein misfolding and neurodegeneration. Arch Neurol 65:184\u2013189. https:\/\/doi.org\/10.1001\/archneurol.2007.56","journal-title":"Arch Neurol"},{"key":"1605_CR10","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/nm.1872","volume":"14","author":"S Schilling","year":"2008","unstructured":"Schilling S, Zeitschel U, Hoffmann T et al (2008) Glutaminyl cyclase inhibition attenuates pyroglutamate A\u03b2 and Alzheimer\u2019s disease\u2014like pathology. Nat Med 14:1106\u20131111. https:\/\/doi.org\/10.1038\/nm.1872","journal-title":"Nat Med"},{"key":"1605_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s40478-016-0380-x","volume":"4","author":"O Sofola-Adesakin","year":"2016","unstructured":"Sofola-Adesakin O, Khericha M, Snoeren I et al (2016) pGluA\u03b2 increases accumulation of A\u03b2 in vivo and exacerbates its toxicity. Acta Neuropathol Commun 4:109. https:\/\/doi.org\/10.1186\/s40478-016-0380-x","journal-title":"Acta Neuropathol Commun"},{"key":"1605_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00401-009-0557-5","volume":"118","author":"O Wirths","year":"2009","unstructured":"Wirths O, Breyhan H, Cynis H et al (2009) Intraneuronal pyroglutamate-A\u03b2 3\u201342 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model. Acta Neuropathol 118:487\u2013496. https:\/\/doi.org\/10.1007\/s00401-009-0557-5","journal-title":"Acta Neuropathol"},{"key":"1605_CR13","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1074\/jbc.M110.185819","volume":"286","author":"S Jawhar","year":"2011","unstructured":"Jawhar S, Wirths O, Schilling S et al (2011) Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A\u03b2 formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice. J Biol Chem 286:4454\u20134460. https:\/\/doi.org\/10.1074\/jbc.M110.185819","journal-title":"J Biol Chem"},{"key":"1605_CR14","doi-asserted-by":"publisher","first-page":"13415","DOI":"10.1021\/bi051142e","volume":"44","author":"S Schilling","year":"2005","unstructured":"Schilling S, Cynis H, von Bohlen A et al (2005) Isolation, catalytic properties, and competitive inhibitors of the zinc-dependent murine glutaminyl cyclase. Biochemistry 44:13415\u201313424. https:\/\/doi.org\/10.1021\/bi051142e","journal-title":"Biochemistry"},{"key":"1605_CR15","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1021\/jm050756e","volume":"49","author":"M Buchholz","year":"2006","unstructured":"Buchholz M, Heiser U, Schilling S et al (2006) The first potent inhibitors for human glutaminyl cyclase: synthesis and structure\u2013activity relationship. J Med Chem 49:664\u2013677. https:\/\/doi.org\/10.1021\/jm050756e","journal-title":"J Med Chem"},{"key":"1605_CR16","doi-asserted-by":"publisher","first-page":"7069","DOI":"10.1021\/jm900969p","volume":"52","author":"M Buchholz","year":"2009","unstructured":"Buchholz M, Hamann A, Aust S et al (2009) Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement. J Med Chem 52:7069\u20137080. https:\/\/doi.org\/10.1021\/jm900969p","journal-title":"J Med Chem"},{"key":"1605_CR17","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1016\/j.bmc.2016.03.064","volume":"24","author":"M Li","year":"2016","unstructured":"Li M, Dong Y, Yu X et al (2016) Inhibitory effect of flavonoids on human glutaminyl cyclase. Bioorg Med Chem 24:2280\u20132286. https:\/\/doi.org\/10.1016\/j.bmc.2016.03.064","journal-title":"Bioorg Med Chem"},{"key":"1605_CR18","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1021\/acs.jmedchem.7b00098","volume":"60","author":"V-H Hoang","year":"2017","unstructured":"Hoang V-H, Tran P-T, Cui M et al (2017) Discovery of potent human glutaminyl cyclase inhibitors as anti-Alzheimer\u2019s agents based on rational design. J Med Chem 60:2573\u20132590. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00098","journal-title":"J Med Chem"},{"key":"1605_CR19","doi-asserted-by":"publisher","first-page":"6664","DOI":"10.1021\/acs.jmedchem.7b00648","volume":"60","author":"M Li","year":"2017","unstructured":"Li M, Dong Y, Yu X et al (2017) Synthesis and evaluation of diphenyl conjugated imidazole derivatives as potential glutaminyl cyclase inhibitors for treatment of Alzheimer\u2019s disease. J Med Chem 60:6664\u20136677. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00648","journal-title":"J Med Chem"},{"key":"1605_CR20","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.bmc.2018.01.015","volume":"26","author":"VTH Ngo","year":"2018","unstructured":"Ngo VTH, Hoang V-H, Tran P-T et al (2018) Potent human glutaminyl cyclase inhibitors as potential anti-Alzheimer\u2019s agents: structure-activity relationship study of Arg-mimetic region. Bioorg Med Chem 26:1035\u20131049. https:\/\/doi.org\/10.1016\/j.bmc.2018.01.015","journal-title":"Bioorg Med Chem"},{"key":"1605_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1124\/jpet.117.240614","volume":"362","author":"T Hoffmann","year":"2017","unstructured":"Hoffmann T, Meyer A, Heiser U et al (2017) Glutaminyl cyclase inhibitor PQ912 improves cognition in mouse models of Alzheimer\u2019s disease\u2014studies on relation to effective target occupancy. J Pharmacol Exp Ther 362:119\u2013130. https:\/\/doi.org\/10.1124\/jpet.117.240614","journal-title":"J Pharmacol Exp Ther"},{"key":"1605_CR22","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1016\/j.bmc.2013.04.005","volume":"21","author":"P-T Tran","year":"2013","unstructured":"Tran P-T, Hoang V-H, Thorat SA et al (2013) Structure\u2013activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl)propyl thiourea template. Bioorg Med Chem 21:3821\u20133830. https:\/\/doi.org\/10.1016\/j.bmc.2013.04.005","journal-title":"Bioorg Med Chem"},{"key":"1605_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nchembio.1790","volume":"11","author":"M Jimenez-Sanchez","year":"2015","unstructured":"Jimenez-Sanchez M, Lam W, Hannus M et al (2015) siRNA screen identifies QPCT as a druggable target for Huntington\u2019s disease. Nat Chem Biol 11:347\u2013354. https:\/\/doi.org\/10.1038\/nchembio.1790","journal-title":"Nat Chem Biol"},{"key":"1605_CR24","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1107\/S2053230X15010389","volume":"71","author":"F DiPisa","year":"2015","unstructured":"DiPisa F, Pozzi C, Benvenuti M et al (2015) The soluble Y115E\u2013Y117E variant of human glutaminyl cyclase is a valid target for X-ray and NMR screening of inhibitors against Alzheimer disease. Acta Cryst F Sect Struct Biol Commun 71:986\u2013992. https:\/\/doi.org\/10.1107\/S2053230X15010389","journal-title":"Acta Cryst F Sect Struct Biol Commun"},{"key":"1605_CR25","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/nprot.2007.198","volume":"2","author":"M Benvenuti","year":"2007","unstructured":"Benvenuti M, Mangani S (2007) Crystallization of soluble proteins in vapor diffusion for x-ray crystallography. Nat Protocols 2:1633\u20131651. https:\/\/doi.org\/10.1038\/nprot.2007.198","journal-title":"Nat Protocols"},{"key":"1605_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1107\/S0907444905039107","volume":"62","author":"AGW Leslie","year":"2006","unstructured":"Leslie AGW (2006) The integration of macromolecular diffraction data. Acta Crystallogr D Biol Crystallogr 62:48\u201357. https:\/\/doi.org\/10.1107\/S0907444905039107","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1605_CR27","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1107\/S090744491003982X","volume":"67","author":"PR Evans","year":"2011","unstructured":"Evans PR (2011) An introduction to data reduction: space-group determination, scaling and intensity statistics. Acta Crystallogr D Biol Crystallogr 67:282\u2013292. https:\/\/doi.org\/10.1107\/S090744491003982X","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1605_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn MD, Ballard CC, Cowtan KD et al (2011) Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 67:235\u2013242. https:\/\/doi.org\/10.1107\/S0907444910045749","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1605_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1107\/S0907444909042589","volume":"66","author":"A Vagin","year":"2010","unstructured":"Vagin A, Teplyakov A (2010) Molecular replacement with MOLREP. Acta Crystallogr D Biol Crystallogr 66:22\u201325. https:\/\/doi.org\/10.1107\/S0907444909042589","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1605_CR30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66:486\u2013501. https:\/\/doi.org\/10.1107\/S0907444910007493","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1605_CR31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/S0907444911001314","volume":"67","author":"GN Murshudov","year":"2011","unstructured":"Murshudov GN, Skub\u00e1k P, Lebedev AA et al (2011) REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr 67:355\u2013367. https:\/\/doi.org\/10.1107\/S0907444911001314","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1605_CR32","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0959-440X(98)80156-5","volume":"8","author":"RA Laskowski","year":"1998","unstructured":"Laskowski RA, MacArthur MW, Thornton JM (1998) Validation of protein models derived from experiment. Curr Opin Struct Biol 8:631\u2013639","journal-title":"Curr Opin Struct Biol"},{"key":"1605_CR33","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.jmb.2008.03.078","volume":"379","author":"H Cynis","year":"2008","unstructured":"Cynis H, Rahfeld J-U, Stephan A et al (2008) Isolation of an isoenzyme of human glutaminyl cyclase: retention in the Golgi complex suggests involvement in the protein maturation machinery. J Mol Biol 379:966\u2013980. https:\/\/doi.org\/10.1016\/j.jmb.2008.03.078","journal-title":"J Mol Biol"},{"key":"1605_CR34","doi-asserted-by":"publisher","first-page":"13117","DOI":"10.1073\/pnas.0504184102","volume":"102","author":"K-F Huang","year":"2005","unstructured":"Huang K-F, Liu Y-L, Cheng W-J et al (2005) Crystal structures of human glutaminyl cyclase, an enzyme responsible for protein N-terminal pyroglutamate formation. PNAS 102:13117\u201313122. https:\/\/doi.org\/10.1073\/pnas.0504184102","journal-title":"PNAS"},{"key":"1605_CR35","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y-C Cheng","year":"1973","unstructured":"Cheng Y-C, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099\u20133108","journal-title":"Biochem Pharmacol"},{"key":"1605_CR36","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1107\/S0907444912001308","volume":"68","author":"PV Afonine","year":"2012","unstructured":"Afonine PV, Grosse-Kunstleve RW, Echols N et al (2012) Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr D Biol Crystallogr 68:352\u2013367. https:\/\/doi.org\/10.1107\/S0907444912001308","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1605_CR37","doi-asserted-by":"publisher","first-page":"12439","DOI":"10.1074\/jbc.M110.208595","volume":"286","author":"K-F Huang","year":"2011","unstructured":"Huang K-F, Liaw S-S, Huang W-L et al (2011) Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding. J Biol Chem 286:12439\u201312449. https:\/\/doi.org\/10.1074\/jbc.M110.208595","journal-title":"J Biol Chem"},{"key":"1605_CR38","doi-asserted-by":"publisher","first-page":"49773","DOI":"10.1074\/jbc.M309077200","volume":"278","author":"S Schilling","year":"2003","unstructured":"Schilling S, Niestroj AJ, Rahfeld J-U et al (2003) Identification of human glutaminyl cyclase as a metalloenzyme potent inhibition by imidazole derivatives and heterocyclic chelators. J Biol Chem 278:49773\u201349779. https:\/\/doi.org\/10.1074\/jbc.M309077200","journal-title":"J Biol Chem"},{"key":"1605_CR39","doi-asserted-by":"publisher","first-page":"e71657","DOI":"10.1371\/journal.pone.0071657","volume":"8","author":"C Castaldo","year":"2013","unstructured":"Castaldo C, Ciambellotti S, de Pablo-Latorre R et al (2013) Soluble variants of human recombinant glutaminyl cyclase. PLoS One 8:e71657. https:\/\/doi.org\/10.1371\/journal.pone.0071657","journal-title":"PLoS One"}],"container-title":["JBIC Journal of Biological Inorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00775-018-1605-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-018-1605-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-018-1605-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T22:35:35Z","timestamp":1661812535000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00775-018-1605-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,21]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1605"],"URL":"https:\/\/doi.org\/10.1007\/s00775-018-1605-1","relation":{},"ISSN":["0949-8257","1432-1327"],"issn-type":[{"value":"0949-8257","type":"print"},{"value":"1432-1327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,21]]},"assertion":[{"value":"29 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}